1st Quarter - Report

MEHLMAN CONSULTING, INC. for AEGIS SCIENCES CORPORATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare contractor issues regarding coverage of testing for opioids, drugs of abuse, and drug interactions. Referral issues regarding laboratory testing. Reimbursement for COVID-19-related expenses. Protecting Access to Medicare Act Laboratory reimbursement reporting delay; Medicare reimbursement for laboratory services. H.R. 2471 - Consolidated Appropriations Act (2022 Omnibus). H.R. 7007 - COVID-19 Supplemental Appropriations Act of 2022.

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2471 (117th), H.R. 7007 (117th)

Health Issues HCR

Referral issues regarding laboratory testing. Reimbursement for COVID-19-related expenses Issues related to government funding and support for COVID testing. Access to COVID-19 testing. H.R. 2471 - Consolidated Appropriations Act (2022 Omnibus). H.R. 7007 - COVID-19 Supplemental Appropriations Act of 2022.

Contacted: SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 7007 (117th), H.R. 2471 (117th)

Medical/Disease Research/Clinical Labs MED

Provisions related to coverage of diagnostic testing.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.